High Incidence of IL-10 mRNA in Breast Tumors
Author Information
Author(s): E Venetsanakos, I Beckman, J Bradley, JM Skinner
Primary Institution: Flinders Medical Centre, South Australia, Australia
Hypothesis
The study investigates the expression of cytokine mRNA in human breast tumors to understand the immune response to tumors.
Conclusion
The study found a high incidence of IL-10 mRNA in breast tumors, suggesting it may inhibit T-cell function and contribute to tumor growth.
Supporting Evidence
- IL-10 mRNA was detected in over 50% of the breast tumors examined.
- IL-2 mRNA was not detected in any of the tumors.
- IL-4 mRNA was detected in only 2 of 26 tumors.
- IL-6 mRNA was detected in 13 of 26 tumors.
- TNF-a mRNA was detected in 9 of 26 tumors.
Takeaway
The study looked at breast tumors and found a lot of a substance called IL-10, which might stop the body's immune cells from fighting the cancer.
Methodology
Cytokine mRNA levels were examined in breast tumor samples using reverse transcriptase polymerase chain reaction (RT-PCR).
Limitations
The study did not find correlations between cytokine expression and clinical features of the tumors.
Participant Demographics
Patients with breast cancer, including various ages and tumor types.
Want to read the original?
Access the complete publication on the publisher's website